Global Mesalazine Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Mesalazine market size will reach 205.36 Million USD in 2025 and is projected to reach 262.69 Million USD by 2032, with a CAGR of 3.58% (2025-2032). Notably, the China Mesalazine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Mesalazine, also known as mesalamine, is a medication used for the treatment of inflammatory bowel disease (IBD), specifically ulcerative colitis and Crohn’s disease. It belongs to a class of drugs called aminosalicylates and works locally in the gastrointestinal tract to reduce inflammation. Mesalazine is available in various forms, including oral tablets, capsules, extended-release tablets, suppositories, and enemas. It is believed to exert its therapeutic effects by inhibiting the production of inflammatory mediators and promoting the healing of the intestinal lining. Mesalazine has been shown to alleviate symptoms of IBD, such as abdominal pain, diarrhea, and rectal bleeding, and to maintain remission in patients with these conditions. As with any medication, mesalazine may have potential side effects, and its use should be closely monitored and guided by a healthcare professional.
The major global manufacturers of Mesalazine include PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Mesalazine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Mesalazine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Mesalazine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Mesalazine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Mesalazine Include:
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Mesalazine Product Segment Include:
Above 97 %
Above 98 %
Above 99 %
Mesalazine Product Application Include:
Tablets
Capsules
Pellet and Granule
Suppository
Enema
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Mesalazine Industry PESTEL Analysis
Chapter 3: Global Mesalazine Industry Porter's Five Forces Analysis
Chapter 4: Global Mesalazine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Mesalazine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Mesalazine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Mesalazine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Mesalazine market size will reach 205.36 Million USD in 2025 and is projected to reach 262.69 Million USD by 2032, with a CAGR of 3.58% (2025-2032). Notably, the China Mesalazine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Mesalazine, also known as mesalamine, is a medication used for the treatment of inflammatory bowel disease (IBD), specifically ulcerative colitis and Crohn’s disease. It belongs to a class of drugs called aminosalicylates and works locally in the gastrointestinal tract to reduce inflammation. Mesalazine is available in various forms, including oral tablets, capsules, extended-release tablets, suppositories, and enemas. It is believed to exert its therapeutic effects by inhibiting the production of inflammatory mediators and promoting the healing of the intestinal lining. Mesalazine has been shown to alleviate symptoms of IBD, such as abdominal pain, diarrhea, and rectal bleeding, and to maintain remission in patients with these conditions. As with any medication, mesalazine may have potential side effects, and its use should be closely monitored and guided by a healthcare professional.
The major global manufacturers of Mesalazine include PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Mesalazine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Mesalazine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Mesalazine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Mesalazine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Mesalazine Include:
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Mesalazine Product Segment Include:
Above 97 %
Above 98 %
Above 99 %
Mesalazine Product Application Include:
Tablets
Capsules
Pellet and Granule
Suppository
Enema
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Mesalazine Industry PESTEL Analysis
Chapter 3: Global Mesalazine Industry Porter's Five Forces Analysis
Chapter 4: Global Mesalazine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Mesalazine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Mesalazine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Mesalazine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Mesalazine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Mesalazine Product by Type
- 1.2.1 Above 97 %
- 1.2.2 Above 98 %
- 1.2.3 Above 99 %
- 1.3 Mesalazine Product by Application
- 1.3.1 Tablets
- 1.3.2 Capsules
- 1.3.3 Pellet and Granule
- 1.3.4 Suppository
- 1.3.5 Enema
- 1.3.6 Others
- 1.4 Global Mesalazine Market Revenue and Sales Analysis
- 1.4.1 Global Mesalazine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Mesalazine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Mesalazine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Mesalazine Market Development Status and Trends
- 1.5.1 Mesalazine Industry Development Status Analysis
- 1.5.2 Mesalazine Industry Development Trends Analysis
- 2 Mesalazine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Mesalazine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Mesalazine Market Analysis by Country
- 4.1 Global Mesalazine Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Mesalazine Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Mesalazine Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Mesalazine Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Mesalazine Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Mesalazine Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Mesalazine Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Mesalazine Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Mesalazine Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Mesalazine Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Mesalazine Average Sales Price by Manufacturers (2021-2025)
- 5.2 Mesalazine Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Mesalazine Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Mesalazine Market Analysis by Type
- 6.1 Global Mesalazine Market Revenue Analysis by Type
- 6.1.1 Global Mesalazine Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Mesalazine Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Mesalazine Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Mesalazine Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 PharmaZell
- 7.1.1 PharmaZell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 PharmaZell Mesalazine Product Portfolio
- 7.1.3 PharmaZell Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Syntese A/S
- 7.2.1 Syntese A/S Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Syntese A/S Mesalazine Product Portfolio
- 7.2.3 Syntese A/S Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Cambrex Corporation
- 7.3.1 Cambrex Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Cambrex Corporation Mesalazine Product Portfolio
- 7.3.3 Cambrex Corporation Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Divis Laboratories
- 7.4.1 Divis Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Divis Laboratories Mesalazine Product Portfolio
- 7.4.3 Divis Laboratories Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Chemi SpA
- 7.5.1 Chemi SpA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Chemi SpA Mesalazine Product Portfolio
- 7.5.3 Chemi SpA Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Ipca Laboratories
- 7.6.1 Ipca Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Ipca Laboratories Mesalazine Product Portfolio
- 7.6.3 Ipca Laboratories Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Hangzhou Brother
- 7.7.1 Hangzhou Brother Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Hangzhou Brother Mesalazine Product Portfolio
- 7.7.3 Hangzhou Brother Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Lianyungang Fengheng Biopharm
- 7.8.1 Lianyungang Fengheng Biopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Lianyungang Fengheng Biopharm Mesalazine Product Portfolio
- 7.8.3 Lianyungang Fengheng Biopharm Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Lasa Loboratory
- 7.9.1 Lasa Loboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Lasa Loboratory Mesalazine Product Portfolio
- 7.9.3 Lasa Loboratory Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Corden Pharma Bergamo
- 7.10.1 Corden Pharma Bergamo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Corden Pharma Bergamo Mesalazine Product Portfolio
- 7.10.3 Corden Pharma Bergamo Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 Erregierre SpA
- 7.11.1 Erregierre SpA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Erregierre SpA Mesalazine Product Portfolio
- 7.11.3 Erregierre SpA Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.12 CTX Lifescience
- 7.12.1 CTX Lifescience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 CTX Lifescience Mesalazine Product Portfolio
- 7.12.3 CTX Lifescience Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.13 Ishita Active Pharma Ingredients
- 7.13.1 Ishita Active Pharma Ingredients Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Ishita Active Pharma Ingredients Mesalazine Product Portfolio
- 7.13.3 Ishita Active Pharma Ingredients Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.14 YC Biotech (Jiangsu)
- 7.14.1 YC Biotech (Jiangsu) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 YC Biotech (Jiangsu) Mesalazine Product Portfolio
- 7.14.3 YC Biotech (Jiangsu) Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.15 Xinxiang Tianfeng Fine Chemical
- 7.15.1 Xinxiang Tianfeng Fine Chemical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio
- 7.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Mesalazine Industry Chain Analysis
- 8.2 Mesalazine Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Mesalazine Product Downstream Application Analysis
- 8.3.1 Global Mesalazine Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Mesalazine Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Mesalazine Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Mesalazine Typical Downstream Customers
- 8.5 Mesalazine Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
